Phase II clinical study of CIM331 in hemodialysis patients with pruritus.
Phase of Trial: Phase II
Latest Information Update: 18 Apr 2017
At a glance
- Drugs Nemolizumab (Primary)
- Indications Pruritus
- Focus Therapeutic Use
- Sponsors Chugai Pharmaceutical
- 11 Apr 2017 Status changed from active, no longer recruiting to completed.
- 14 Sep 2016 Status changed from recruiting to active, no longer recruiting.
- 08 Jun 2016 New trial record